APRI +13% another solid day. 10 years ago? lol. Recently, Selvaraju tells investors in a research note- The analyst raised his probability of success for Vitaros to 80% from 70% and reiterates a Buy rating on Apricus. He believes that Allergan (AGN), which has an opt-in agreement for Vitaros, may choose to acquire Apricus if the topical cream secures U.S. approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.